2.02
price up icon2.02%   0.04
after-market Handel nachbörslich: 1.97 -0.05 -2.48%
loading
Schlusskurs vom Vortag:
$1.98
Offen:
$1.97
24-Stunden-Volumen:
108.13K
Relative Volume:
0.73
Marktkapitalisierung:
$220.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-60.14M
KGV:
-2.8471
EPS:
-0.7095
Netto-Cashflow:
$-68.17M
1W Leistung:
-2.42%
1M Leistung:
+22.80%
6M Leistung:
-29.12%
1J Leistung:
-47.80%
1-Tages-Spanne:
Value
$1.97
$2.065
1-Wochen-Bereich:
Value
$1.65
$2.1689
52-Wochen-Spanne:
Value
$1.4299
$4.26

Ac Immune Sa Stock (ACIU) Company Profile

Name
Firmenname
Ac Immune Sa
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
172
Name
Twitter
@AC_Immune_SA
Name
Nächster Verdiensttermin
2025-04-28
Name
Neueste SEC-Einreichungen
Name
ACIU's Discussions on Twitter

Vergleichen Sie ACIU mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ACIU
Ac Immune Sa
2.02 220.90M 0 -60.14M -68.17M -0.7095
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Ac Immune Sa Stock (ACIU) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-31 Eingeleitet BTIG Research Buy
2019-02-01 Herabstufung UBS Buy → Neutral
2019-01-04 Eingeleitet UBS Buy
2018-04-05 Eingeleitet H.C. Wainwright Buy
2018-03-23 Herabstufung Credit Suisse Outperform → Neutral
2016-10-18 Eingeleitet Credit Suisse Outperform
2016-10-18 Eingeleitet Jefferies Buy
2016-10-18 Eingeleitet Leerink Partners Outperform
Alle ansehen

Ac Immune Sa Aktie (ACIU) Neueste Nachrichten

pulisher
Jun 16, 2025

Handelsbanken Fonder AB Trims Stake in AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

AC Immune SA Announces Executive Changes - MarketScreener

Jun 12, 2025
pulisher
Jun 11, 2025

AC Immune SA Announces Leadership Changes in Development Team - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

AC Immune SA (NASDAQ:ACIU) Held Back By Insufficient Growth Even After Shares Climb 31% - simplywall.st

Jun 11, 2025
pulisher
Jun 11, 2025

Millennium Management LLC Sells 47,100 Shares of AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Promising Renewable Energy Stocks To Watch Now – June 9th - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Invests $118,000 in AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

June 2025 Penny Stocks With Promising Potential - simplywall.st

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Buys Shares of 24,283 AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Acquires Shares of 13,410 AC Immune SA (NASDAQ:ACIU) - Defense World

Jun 09, 2025
pulisher
Jun 03, 2025

ACIUAC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - mx.advfn.com

Jun 03, 2025
pulisher
May 29, 2025

Northern Trust Corp Makes New Investment in AC Immune SA (NASDAQ:ACIU) - Defense World

May 29, 2025
pulisher
May 21, 2025

Individual investors among AC Immune SA's (NASDAQ:ACIU) largest shareholders, saw gain in holdings value after stock jumped 11% last week - simplywall.st

May 21, 2025
pulisher
May 21, 2025

TRIALS UPDATE: The Latest Alzheimer’s Drug Development News (Q1 2025) - Being Patient

May 21, 2025
pulisher
May 19, 2025

AC Immune SA Announces Board Changes Ahead of June 2025 AGM - TipRanks

May 19, 2025
pulisher
May 17, 2025

Dimensional Fund Advisors LP Has $355,000 Stock Holdings in AC Immune SA (NASDAQ:ACIU) - Defense World

May 17, 2025
pulisher
May 15, 2025

AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by StockNews.com - Defense World

May 15, 2025
pulisher
May 13, 2025

AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - ADVFN

May 13, 2025
pulisher
May 10, 2025

AC Immune (ACIU) to Release Earnings on Monday - Defense World

May 10, 2025
pulisher
May 06, 2025

AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating - TipRanks

May 06, 2025
pulisher
May 06, 2025

AC Immune (NASDAQ:ACIU) Downgraded by StockNews.com to “Hold” - Defense World

May 06, 2025
pulisher
May 05, 2025

Equities Analysts Issue Forecasts for AC Immune Q2 Earnings - Defense World

May 05, 2025
pulisher
May 04, 2025

FY2027 EPS Estimates for AC Immune Cut by HC Wainwright - Defense World

May 04, 2025
pulisher
May 03, 2025

HC Wainwright Lowers AC Immune (NASDAQ:ACIU) Price Target to $12.00 - Defense World

May 03, 2025
pulisher
May 02, 2025

Planning For Perseverance - Life Science Leader

May 02, 2025
pulisher
May 01, 2025

AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 01, 2025
pulisher
May 01, 2025

AC Immune (ACIU) Stock Rating Maintained, Price Target Lowered | - GuruFocus

May 01, 2025
pulisher
May 01, 2025

H.C. Wainwright cuts AC Immune SA target to $12; maintains buy - Investing.com

May 01, 2025
pulisher
May 01, 2025

AC Immune (ACIU) Target Price Reduced by H.C. Wainwright | ACIU Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

AC Immune price target lowered to $12 from $16 at H.C. Wainwright - TipRanks

May 01, 2025
pulisher
Apr 30, 2025

AC Immune: Q1 Earnings Snapshot - MySA

Apr 30, 2025
pulisher
Apr 30, 2025

AC Immune reports Q1 EPS (19c) vs (18c) last year - TipRanks

Apr 30, 2025
pulisher
Apr 30, 2025

AC Immune Reports Q1 2025 Financial Results - TipRanks

Apr 30, 2025
pulisher
Apr 30, 2025

ACIU Surpasses Revenue Expectations with Strong Phase 2 Data | A - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

AC Immune SA Reports Q1 2025 Financial Results and Clinical Advancements in Neurodegenerative Disease Therapies - Nasdaq

Apr 30, 2025
pulisher
Apr 30, 2025

AC Immune Q1 Results: Breakthrough in Parkinson's Treatment Shows Promise, Cash Runway Extended to 2027 - Stock Titan

Apr 30, 2025
pulisher
Apr 29, 2025

Precision Prevention: The Latest on Alzheimer’s Vaccines - Being Patient

Apr 29, 2025
pulisher
Apr 27, 2025

Renaissance Technologies LLC Has $2 Million Stock Position in AC Immune SA (NASDAQ:ACIU) - American Banking and Market News

Apr 27, 2025
pulisher
Apr 26, 2025

Individual investors in AC Immune SA (NASDAQ:ACIU) are its biggest bettors, and their bets paid off as stock gained 11% last week - Yahoo Finance

Apr 26, 2025
pulisher
Apr 25, 2025

Wells Fargo & Company MN Lowers Stock Holdings in AC Immune SA (NASDAQ:ACIU) - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

Is tau approaching a tipping point in Alzheimer’s drug development? - BioCentury

Apr 24, 2025
pulisher
Apr 17, 2025

Q2 Earnings Estimate for AC Immune Issued By Leerink Partnrs - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Q1 Earnings Estimate for AC Immune Issued By Leerink Partnrs - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

AC Immune unveils first-in-class Morphomer targeting pathological α-synuclein - BioWorld MedTech

Apr 15, 2025
pulisher
Apr 10, 2025

ADPD 2025: Novel treatment modalities in neurodegenerative disorders - BioWorld MedTech

Apr 10, 2025

Finanzdaten der Ac Immune Sa-Aktie (ACIU)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):